Virginia Regulatory Town Hall

Proposed Text

highlight

Action:
Disclosure requirement for prescriptions
Stage: Fast-Track
 
18VAC85-50-160

18VAC85-50-160. Disclosure.

A. Each prescription for a Schedule II through V drug shall bear the name of the supervising physician and of the physician assistant.

B. The physician assistant shall disclose to the patient that he is a licensed physician assistant, and also the name, address and telephone number of the supervising physician. Such disclosure may shall either be included on the prescription pad or may be given in writing to the patient.